But of course, every drug, and especially every blockbuster drug, comes with major questions, such as why do GLP-1s seem to have an impact on such a wide range of ailments
Weight loss requires a calorie deficit, which semaglutide creates through appetite suppression, not instant metabolic magic
Hagen TM, Wierzbicka GT, Bowman BB, et al
The back-to-back arguments on tirzepatide, the active ingredient in Eli Lillys Mounjaro and Zepbound, and the related semaglutide case, Novo Nordisks Ozempic and Wegovy, boiled down to two questions: Did the FDA follow the right procedure, and did it actually look at the facts fairly
In clinical trials, around 44 percent of people taking the 2.4-milligram (mg) dose of semaglutide (the highest dose of Wegovy) experienced nausea, as opposed to about 20 percent of people taking a 1-milligram dose of semaglutide